Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Sakurada

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular DegenerationShuhei Hosoda, Yoichi Sakurada, Yoshiko Fukuda, et al.
Retinal Cases & Brief Reports|October 6, 2018
DOCUMENTATION OF A NEW CHOROIDAL NEVUSRavi Parikh, Orly Gal-Or, Yoichi Sakurada, et al.
American Journal of Ophthalmology|April 20, 2010
Estrogen receptor beta gene polymorphism and intraocular pressure elevation in female patients with primary open-angle glaucomaFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 24, 2016
Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular DegenerationWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 19, 2016
Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathyWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
Ophthalmic Genetics|May 29, 2014
Genetic variants in the SKIV2L gene in exudative age-related macular degeneration in the Japanese populationSeigo Yoneyama, Yoichi Sakurada, Fumihiko Mabuchi, et al.
Investigative Ophthalmology & Visual Science|April 22, 2011
Association between SRBD1 and ELOVL5 gene polymorphisms and primary open-angle glaucomaFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
American Journal of Ophthalmology|April 11, 2008
Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathyYoichi Sakurada, Takeo Kubota, Fumihiko Mabuchi, et al.
Ophthalmology|May 16, 2012
Association between genetic variants associated with vertical cup-to-disc ratio and phenotypic features of primary open-angle glaucomaFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
Molecular Vision|May 28, 2009
Lack of association between p53 gene polymorphisms and primary open angle glaucoma in the Japanese populationFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular DegenerationShuhei Hosoda, Yoichi Sakurada, Yoshiko Fukuda, et al.
Retinal Cases & Brief Reports|October 6, 2018
DOCUMENTATION OF A NEW CHOROIDAL NEVUSRavi Parikh, Orly Gal-Or, Yoichi Sakurada, et al.
American Journal of Ophthalmology|April 20, 2010
Estrogen receptor beta gene polymorphism and intraocular pressure elevation in female patients with primary open-angle glaucomaFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 24, 2016
Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular DegenerationWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 19, 2016
Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathyWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
Ophthalmic Genetics|May 29, 2014
Genetic variants in the SKIV2L gene in exudative age-related macular degeneration in the Japanese populationSeigo Yoneyama, Yoichi Sakurada, Fumihiko Mabuchi, et al.
Investigative Ophthalmology & Visual Science|April 22, 2011
Association between SRBD1 and ELOVL5 gene polymorphisms and primary open-angle glaucomaFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
American Journal of Ophthalmology|April 11, 2008
Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathyYoichi Sakurada, Takeo Kubota, Fumihiko Mabuchi, et al.
Ophthalmology|May 16, 2012
Association between genetic variants associated with vertical cup-to-disc ratio and phenotypic features of primary open-angle glaucomaFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
Molecular Vision|May 28, 2009
Lack of association between p53 gene polymorphisms and primary open angle glaucoma in the Japanese populationFumihiko Mabuchi, Yoichi Sakurada, Kenji Kashiwagi, et al.
Pageof 12